Mar 04, 2021 4:15pm EST Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference
Feb 16, 2021 4:45pm EST Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
Feb 10, 2021 11:00pm EST Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
Feb 01, 2021 5:16pm EST Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market
Jan 28, 2021 4:01pm EST Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market
Jan 07, 2021 4:05pm EST Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright
Nov 02, 2020 4:00pm EST Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
Oct 28, 2020 9:55pm EDT Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million
